Bioequivalence of Saxagliptin/Metformin Immediate Release (IR) Fixed-Dose Combination Tablets and Single-Component Saxagliptin and Metformin IR Tablets in Healthy Adult Subjects

被引：0
|
作者：
Vijay V. Upreti
Chi-Fung Keung
David W. Boulton
Ming Chang
Li Li
Angela Tang
Bonnie C. Hsiang
Donette Quamina-Edghill
Ernst U. Frevert
Frank P. LaCreta
机构：
[1] Discovery Medicine and Clinical Pharmacology,
[2] Bristol-Myers Squibb Company (BMS),undefined
[3] Global Biometric Sciences,undefined
[4] BMS,undefined
来源：
Clinical Drug Investigation | 2013年 / 33卷
关键词：
Metformin; Saxagliptin; Immediate Release; Bioequivalence Study; Study Drug Administration;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：365 / 374
页数：9
相关论文
共 50 条
  • [1] Bioequivalence of Saxagliptin/Metformin Immediate Release (IR) Fixed-Dose Combination Tablets and Single-Component Saxagliptin and Metformin IR Tablets in Healthy Adult Subjects
    Upreti, Vijay V.
    Keung, Chi-Fung
    Boulton, David W.
    Chang, Ming
    Li, Li
    Tang, Angela
    Hsiang, Bonnie C.
    Quamina-Edghill, Donette
    Frevert, Ernst U.
    LaCreta, Frank P.
    [J]. CLINICAL DRUG INVESTIGATION, 2013, 33 (05) : 365 - 374
  • [2] Bioequivalence of Saxagliptin/Metformin Extended-Release (XR) Fixed-Dose Combination Tablets and Single-Component Saxagliptin and Metformin XR Tablets in Healthy Adult Subjects
    David W. Boulton
    Charles H. Smith
    L. Li
    Jian Huang
    Angela Tang
    Frank P. LaCreta
    [J]. Clinical Drug Investigation, 2011, 31 : 619 - 630
  • [3] Bioequivalence of Saxagliptin/Metformin Extended-Release (XR) Fixed-Dose Combination Tablets and Single-Component Saxagliptin and Metformin XR Tablets in Healthy Adult Subjects
    Boulton, David W.
    Smith, Charles H.
    Li, L.
    Huang, Jian
    Tang, Angela
    LaCreta, Frank P.
    [J]. CLINICAL DRUG INVESTIGATION, 2011, 31 (09) : 619 - 630
  • [4] Bioequivalence of Saxagliptin/Metformin Extended-Release (XR) Fixed-Dose Combination Tablets and Single-Component Saxagliptin and Metformin XR Tablets in Healthy Adult Chinese Subjects
    Gummesson, Anders
    Li, Haiyan
    Gillen, Michael
    Xu, John
    Niazi, Mohammad
    Hirshberg, Boaz
    [J]. CLINICAL DRUG INVESTIGATION, 2014, 34 (11) : 763 - 772
  • [5] Bioequivalence of Saxagliptin/Metformin Extended-Release (XR) Fixed-Dose Combination Tablets and Single-Component Saxagliptin and Metformin XR Tablets in Healthy Adult Chinese Subjects
    Anders Gummesson
    Haiyan Li
    Michael Gillen
    John Xu
    Mohammad Niazi
    Boaz Hirshberg
    [J]. Clinical Drug Investigation, 2014, 34 : 763 - 772
  • [6] Bioequivalence of saxagliptin/dapagliflozin fixed-dose combination tablets compared with coadministration of the individual tablets to healthy subjects
    Vakkalagadda, Blisse
    Vetter, Marion L.
    Rana, Jignasa
    Smith, Charles H.
    Huang, Jian
    Karkas, Jennifer
    Boulton, David W.
    LaCreta, Frank
    [J]. PHARMACOLOGY RESEARCH & PERSPECTIVES, 2015, 3 (06): : 1 - 12
  • [7] Bioequivalence of vildagliptin/metformin fixed-dose combination tablets and a free combination of vildagliptin and metformin in healthy subjects
    He, Y-L.
    Paladini, S.
    Sabia, H.
    Campestrini, J.
    Zhan, Y.
    Leon, S.
    Ligueros-Saylan, M.
    Jarugula, V.
    [J]. INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 2008, 46 (05) : 259 - 267
  • [8] Bioequivalence of fixed-dose combinations of dapagliflozin and metformin with single-component tablets in healthy subjects and the effect of food on bioavailability
    de Bruin, Tjerk W. A.
    Reele, Stots
    Hamer-Maansson, Jennifer E.
    Parikh, Shamik
    Tang, Weifeng
    [J]. CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT, 2016, 5 (02): : 118 - 130
  • [9] Fed and Fasted Single-dose Assessment of Bioequivalence of Dapagliflozin and Metformin Extended-release Fixed-dose Combination Tablets Relative to Single-component Dapagliflozin and Metformin Extended-release Tablets in Healthy Subjects
    Boulton, David W.
    Chang, Ming
    Griffen, Steven C.
    Kitaura, Catia
    Lubin, Susan
    Pollack, Allyson
    LaCreta, Frank
    [J]. CLINICAL THERAPEUTICS, 2016, 38 (01) : 99 - 109
  • [10] Bioequivalence of macitentan and tadalafil given as fixed-dose combination or single-component tablets in healthy subjects
    Grill, Simon
    Bruderer, Shirin
    Sidharta, Patricia N.
    Antonova, Mariya
    Globig, Susanne
    Carlson, James
    Schultz, Armin
    Csonka, Denes
    [J]. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2020, 86 (12) : 2424 - 2434
12345